Trade Ideas November 19, 2026 08:24 AM

Celestica: Upgrade to Buy — Re-enter Ahead of AI Infrastructure Tailwinds

Solid cash flow, improving margins and low leverage make CLS a high-conviction long trade into 2027

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
CLS

Celestica (CLS) looks primed for a renewed run. Strong revenue and EPS upside, improving operating margins and a clean balance sheet support a long trade at current levels. We upgrade to Buy with a clear entry at $255.80, target $350.00 and stop at $225.00 — a long-term trade (180 trading days) sized for investors comfortable with cyclical EMs exposure.

Celestica: Upgrade to Buy — Re-enter Ahead of AI Infrastructure Tailwinds
CLS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Celestica benefits from strong AI/hyperscale demand via its CCS segment, driving outsized near-term revenue growth.
  • Company financials show $545.4M free cash flow, low leverage (debt/equity ~0.13), and ROE ~20%, supporting reinvestment and margin durability.
  • Valuation (mid-20s P/E, EV/sales ~1.5x) looks reasonable versus expected high EPS growth if execution continues.
  • Trade: Entry $255.80, Target $350.00, Stop $225.00. Horizon: long term (180 trading days).

Hook & thesis

Celestica is a classic winner from the AI and cloud buildout that has already started to flow through electronics manufacturing services (EMS) vendors. The market has punished CLS in recent months, but the company is delivering rapid top-line growth, fatter margins and free cash flow at scale. With a market cap of roughly $30.7 billion and an enterprise value near $27.5 billion, the balance of fundamentals and risk-reward now favors an entry for disciplined long investors.

We are upgrading CLS to Buy and recommending a tactical long — entry $255.80, target $350.00, stop $225.00 — sized for a long-term hold of 180 trading days. The thesis: accelerating AI/networking demand should sustain above-industry revenue growth, while structurally improved margins and a low debt footprint convert that growth into meaningful cash flow and ROE expansion.

Business snapshot - what Celestica does and why it matters

Celestica operates as an EMS provider split into two segments: Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS). ATS covers aerospace and defense, industrial, smart energy and health tech. CCS serves enterprise communications, telecom, servers and storage - the segment most exposed to AI and hyperscale spending.

The market cares because EMS players act as demand multipliers for the AI supply chain. As customers standardize on higher-density switches, optical modules and custom servers, contract manufacturers with scale, engineering depth and capacity allocation win market share and pricing power. Celestica checks those boxes: it reported outsized revenue growth in recent quarters and management has pushed margins higher while keeping leverage low.

What the numbers say

Concrete metrics back the bullish view. Market-capitalization sits at approximately $30.7 billion with enterprise value of ~$27.5 billion. The company reported free cash flow of $545.4 million most recently, and the balance sheet is conservative: debt-to-equity ~0.13 and current ratio ~1.61, leaving operating flexibility to scale production.

Profitability metrics are improving. Reported return on equity is about 20.05% and return on assets 8.23%. Price multiples are reasonable given growth: trailing price-to-earnings per one snapshot is ~24.6x, and price-to-sales around 1.68x, which look attractive when paired with analyst growth expectations highlighted in recent coverage (consensus EPS growth and model revisions pointing to very large year-over-year percentage gains for 2026 and 2027).

Technicals show a momentum inflection: the 9-day EMA recently crossed up near the 10–20 day band and the MACD histogram is signaling bullish momentum after a period of consolidation. RSI sits mid-range at ~43, suggesting room to run without being overbought.

Valuation framing

At a market cap just north of $30 billion and enterprise value about $27.5 billion, Celestica is trading at multiples that reflect strong forward growth but not frothy expectations. Trailing P/E in the mid-20s and EV/sales around 1.5x imply the market is giving credit for growth but not assigning a premium multiple like pure software names. Given the company's low leverage, $545 million of free cash flow and improving operating margin trends (recent reports cited a record ~8.5% operating margin in a quarter), the multiple seems supportable if Celestica can sustain high-teens to double-digit revenue growth over the next several quarters.

In short: you are paying mid-20s earnings multiple for what looks like high-teens to potentially triple-digit EPS growth in the next year in some analyst models. That gap is the opportunity for a trade — the market reprices growth into higher multiples when delivery is consistent, and CLS has the balance sheet and cash-flow characteristics to deliver.

Catalysts to drive the move

  • Continued AI and hyperscale networking demand ramp - higher allocation of server, switch and optical spend into CCS should sustain outsized revenue growth.
  • Margin expansion from better product mix and scale - management has flagged improving operating margins and recorded a company-high operating margin recently; sustaining that will drive EPS lift.
  • Positive analyst revisions and coverage - several recent notes (mid-November coverage) have upgraded estimates and highlighted 80-90% EPS growth expectations for the near term, which fuels re-rating.
  • Free cash flow conversion - with $545.4 million in FCF and modest leverage (debt/equity ~0.13), any acceleration in FCF margin could be returned to shareholders or reinvested to expand high-margin lines of business.

Trade plan

We recommend entering the position at $255.80 with a stop loss at $225.00 and a primary target of $350.00. This is designed as a long-term trade for 180 trading days, giving the company time to report at least one full quarter and allowing catalysts (order momentum, margin narrative and analyst revisions) to play out.

Entry Stop Target Horizon Risk Level
$255.80 $225.00 $350.00 Long term (180 trading days) Medium

Why long-term (180 trading days)? Two reasons. First, revenue recognition and supply-chain ramps in EMS often show up across sequential quarters as capacity comes online and order books convert to shipments. Second, analyst revisions and investor sentiment take time to translate into a higher multiple; 180 trading days lets both fundamental delivery and re-rating occur.

Position sizing & risk framing

This trade sits in the medium-risk bucket. Celestica has a clean capital structure and strong FCF generation, but EMS exposure is cyclical and customer concentration in networking/server markets can produce quarter-to-quarter volatility. We recommend sizing the position so that a stop-triggered exit at $225 results in a portfolio-level loss you can absorb — for many investors that will be 1-3% of portfolio value on initial position sizing.

Risks and counterarguments

  • Demand volatility - EMS revenue can be lumpy. A single large customer deferring orders or inventory destocking in the industry could reverse the growth trajectory and pressure margins.
  • Geopolitical / supply-chain shocks - trade restrictions, component shortages or renewed export controls (recall recent headlines around chip export policy) could compress both top-line growth and margins.
  • Valuation re-rating delays - even with robust organic growth, multiples may stay muted if macro sentiment toward cyclical manufacturers deteriorates or if investor attention shifts away from hardware-oriented names.
  • Execution risk on margin expansion - higher gross margins depend on mix shift into high-margin AI/networking products. Failure to secure favorable cost structures or to ramp production efficiently could stall EPS leverage.
  • Counterargument: the stock has already rallied off lows, and much of the AI narrative may be priced in. If future quarters deliver slower-than-expected revenue growth or margin contraction, the stock can quickly give back gains because of concentrated sentiment around AI winners.

What would change our mind

We would become more bullish if Celestica posts consecutive quarters of double-digit organic revenue growth in the CCS segment, sustained operating margin above ~8-9% and free cash flow conversion meaningfully above the current run-rate. Conversely, we would downgrade if order cancellations emerge, if operating margins retrench materially (e.g., below 5%) or if leverage increases meaningfully beyond the low current level (debt/equity moves well above 0.5).

Conclusion

Celestica checks the boxes for a patient long: accelerating AI-driven demand, improving margins, robust free cash flow and a conservative balance sheet. The stock carries cyclical risk and execution is not guaranteed, but the risk-reward at $255.80 into a $350 target and a $225 stop is attractive for investors who can tolerate EMS volatility. We upgrade CLS to Buy and recommend initiating a long-term position for 180 trading days, monitoring quarterly delivery and margin progression closely.

Key upcoming readouts to watch

  • Quarterly revenue cadence and CCS segment growth rate - look for sustained high-teens to 80%+ year-over-year prints per recent analyst headlines.
  • Operating margin trajectory - confirm management can hold the improved margin run-rate.
  • Free cash flow and working capital trends - watch conversion and days-sales-in-inventory for signs of capacity/working capital stress.

Trade idea: Buy Celestica (CLS) at $255.80, stop $225.00, target $350.00. Long-term (180 trading days). Medium risk.

Risks

  • Cyclical demand: EMS revenues are lumpy; a major customer delay or sector-wide destocking could quickly compress sales and margins.
  • Geopolitical and supply-chain disruptions: export controls or component shortages could interrupt production and hurt profitability.
  • Execution on margin expansion: sustained improvement depends on product mix and operational efficiency; failure would stall EPS growth.
  • Valuation risk: market may not re-rate cyclical hardware names promptly even if fundamentals improve, leading to extended sideways price action.

More from Trade Ideas

Nebius at a Discount: Buy the AI Compute Marketplace Dip After a 65% Slide Nov 19, 2026 Tesla's Optionality Is Priced In - But It Still Looks Like a Buy at Today's Levels Nov 19, 2026 Buy UNP: Operational Momentum and Merger Optionality Support a Mid‑Term Long Nov 19, 2026 United Airlines: Fuel Tailwind But Heavy Fleet Bill Keeps Me on the Sidelines Nov 19, 2026 Brookfield Renewable: Reliable Cash Flow, Visible Catalysts, and an Attractive Entry Nov 19, 2026